- Home
- ALZN vs STSS Comparison
ALZN vs STSS Comparison
Compare ALZN & STSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALZN
- STSS
- Stock Information
- Founded
- ALZN 2016
- STSS 2017
- Country
- ALZN United States
- STSS United States
- Employees
- ALZN N/A
- STSS N/A
- Industry
- ALZN Medicinal Chemicals and Botanical Products
- STSS Medical/Dental Instruments
- Sector
- ALZN Health Care
- STSS Health Care
- Exchange
- ALZN Nasdaq
- STSS Nasdaq
- Market Cap
- ALZN 7.0M
- STSS 6.9M
- IPO Year
- ALZN 2021
- STSS 2022
- Fundamental
- Price
- ALZN $1.11
- STSS $1.88
- Analyst Decision
- ALZN Strong Buy
- STSS
- Analyst Count
- ALZN 1
- STSS 0
- Target Price
- ALZN $32.00
- STSS N/A
- AVG Volume (30 Days)
- ALZN 174.7K
- STSS 384.2K
- Earning Date
- ALZN 12-31-2024
- STSS 11-14-2024
- Dividend Yield
- ALZN N/A
- STSS N/A
- EPS Growth
- ALZN N/A
- STSS N/A
- EPS
- ALZN N/A
- STSS N/A
- Revenue
- ALZN N/A
- STSS N/A
- Revenue This Year
- ALZN N/A
- STSS N/A
- Revenue Next Year
- ALZN N/A
- STSS N/A
- P/E Ratio
- ALZN N/A
- STSS N/A
- Revenue Growth
- ALZN N/A
- STSS N/A
- 52 Week Low
- ALZN $1.06
- STSS $1.70
- 52 Week High
- ALZN $15.06
- STSS $18.15
- Technical
- Relative Strength Index (RSI)
- ALZN 34.55
- STSS 34.08
- Support Level
- ALZN $1.16
- STSS $1.92
- Resistance Level
- ALZN $1.33
- STSS $2.15
- Average True Range (ATR)
- ALZN 0.09
- STSS 0.27
- MACD
- ALZN 0.01
- STSS -0.03
- Stochastic Oscillator
- ALZN 17.86
- STSS 14.52
About ALZN Alzamend Neuro Inc.
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.
About STSS Sharps Technology Inc.
Sharps Technology Inc is a medical device company. It offers syringes and other safety products. Sharps provensa, Securgard, and Sologard are ultra-low waste smart safety syringes are designed to eliminate potentially infectious and accidental needlestick injuries.